Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.

MLA

Hale, G., et al. “Improving the Outcome of Bone Marrow Transplantation by Using CD52 Monoclonal Antibodies to Prevent Graft-versus-Host Disease and Graft Rejection.” Blood, vol. 92, no. 12, Dec. 1998, pp. 4581–90. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9845524&authtype=sso&custid=ns315887.

APA

Hale, G., Zhang, M. J., Bunjes, D., Prentice, H. G., Spence, D., Horowitz, M. M., Barrett, A. J., & Waldmann, H. (1998). Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. Blood, 92(12), 4581–4590.

Chicago

Hale, G, M J Zhang, D Bunjes, H G Prentice, D Spence, M M Horowitz, A J Barrett, and H Waldmann. 1998. “Improving the Outcome of Bone Marrow Transplantation by Using CD52 Monoclonal Antibodies to Prevent Graft-versus-Host Disease and Graft Rejection.” Blood 92 (12): 4581–90. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9845524&authtype=sso&custid=ns315887.